Zepbound (tirzepatide) Approved uses: People with overweight or obesity and moderate-to-severe obstructive sleep apnea Drug type: Once-weekly injection Doses: 2.5 mg (initial dose), 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg Cost: With commercial insurance that includes Zepbound coverage, the cost of a three-month prescription is as low as $25
Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion
Kidney Int Rep 8(11):22542264 Giugliano D, Longo M, Scappaticcio L et al (2021) SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs
With more anterior COM, the center of pressure under the foot shifts and loading patterns change, increasing shear stresses and risk for plantar pain and lower-extremity injuries